ASX ANNOUNCEMENT RESULTS OF ANNUAL GENERAL MEETING Perth, Australia; 19 NOVEMBER 2026 – Argenica Therapeutics Limited (ASX: AGN) (“Argenica” or the “Company”) held its Annual General Meeting of Shareholders at 2.00 PM (WST) on 19 November 2026 and advises that all resolutions were passed...
Argenica Therapeutics: Results of Annual General Meeting
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Argenica Therapeutics Ltd held its Annual General Meeting and all resolutions were passed by a poll. The filing provides details of the proxy votes and votes cast for each resolution. The resolutions included the adoption of the remuneration report and the re-election of a director. The results indicate strong support for the proposed resolutions from shareholders.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Argenica Therapeutics Ltd on 6ix
Story so far
Earlier from Argenica Therapeutics
- AGM Chair Address & Presentation
- FDA Feedback Received, Requests Additional Rat Study
- Becoming a substantial holder
- Quarterly Activities/Appendix 4C Cash Flow Report
- New Mechanism Findings Offer Insights Into Phase 2 Signal
Follow Argenica Therapeutics into a list and get an email when it puts out news.
Follow Argenica Therapeutics